Patents by Inventor Cecilia Speyer

Cecilia Speyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IGA FC-FOLATE CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND METHODS TO TREAT CANCER
    Publication number: 20210393788
    Abstract: IgA-based Fc-folate conjugates as a treatment for cancer are provided. The conjugates utilize only the Fc portion of IgA to target its receptor on neutrophils (Fc?R1) to elicit antibody-dependent cellular-cytotoxicity (ADCC).
    Type: Application
    Filed: September 3, 2021
    Publication date: December 23, 2021
    Applicant: Wayne State University
    Inventor: Cecilia Speyer
  • IGA FC-folate conjugates, pharmaceutical compositions and methods to treat cancer
    Patent number: 11135302
    Abstract: IgA-based Fc-folate conjugates as a treatment for cancer are provided. The conjugates utilize only the Fc portion of IgA to target its receptor on neutrophils (Fc?R1) to elicit antibody-dependent cellular-cytotoxicity (ADCC).
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: October 5, 2021
    Assignee: Wayne State University
    Inventor: Cecilia Speyer
  • IGA FC-FOLATE CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND METHODS TO TREAT CANCER
    Publication number: 20190262462
    Abstract: IgA-based Fc-folate conjugates as a treatment for cancer are provided. The conjugates utilize only the Fc portion of IgA to target its receptor on neutrophils (Fc?R1) to elicit antibody-dependent cellular-cytotoxicity (ADCC).
    Type: Application
    Filed: May 10, 2019
    Publication date: August 29, 2019
    Applicant: Wayne State University
    Inventor: Cecilia Speyer
  • IgA Fc-folate conjugates, pharmaceutical compositions and methods to treat cancer
    Patent number: 10286080
    Abstract: IgA-based Fc-folate conjugates as a treatment for cancer are provided. The conjugates utilize only the Fc portion of IgA to target its receptor on neutrophils (Fc?R1) to elicit antibody-dependent cellular-cytotoxicity (ADCC).
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: May 14, 2019
    Assignee: Wayne State University
    Inventor: Cecilia Speyer
  • IGA FC-FOLATE CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND METHODS TO TREAT CANCER
    Publication number: 20170035901
    Abstract: IgA-based Fc-folate conjugates as a treatment for cancer are provided. The conjugates utilize only the Fc portion of IgA to target its receptor on neutrophils (Fc?R1) to elicit antibody-dependent cellular-cytotoxicity (ADCC).
    Type: Application
    Filed: August 3, 2016
    Publication date: February 9, 2017
    Applicant: WAYNE STATE UNIVERSITY
    Inventor: Cecilia Speyer